Drug Use Study With Intuniv® in European Countries

CompletedOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
OTHER

No Intervention

This is an observational study utilizing historical de-identified patient level data; therefore no intervention is given.

Trial Locations (1)

80637

Real World Insights EMEA IQVIA Commercial GmbH & Co. OHG, Munich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT05870605 - Drug Use Study With Intuniv® in European Countries | Biotech Hunter | Biotech Hunter